Clarithromycin News
Ranbaxy receives USFDA approval for anti-bacterial drug
Ranbaxy Laboratiories Ltd, India's largest drug firm by revenue, on Friday said it has received US Food and Drug Administration's (USFDA) final approval to manufacture and market anti-bacterial drug oral Clarithromycin in...
US court affirms Biaxin patent ruling against Andrx
A U.S. appeals court on Friday upheld a lower court ruling blocking Andrx Pharmaceuticals from selling a generic version of Abbott Laboratories Inc.'s extended-release antibiotic Biaxin.
Involvement of mitochondria and caspase pathways in N-demethyl-clarithromycin-induced apoptosis in human cervical cancer HeLa cell.
AIM: To study the mechanisms by which N-demethyl-clarithromycin (NDC) induces human cervical cancer HeLa cell apoptosis in vitro.
Abbott fails to block copy of antibiotic
Abbott Laboratories has lost a bid to stop Novartis AG's Sandoz unit from selling a generic copy of the extended release version of the antibiotic Biaxin.
Clarithromycin treatment and QT prolongation in childhood.
The effect of clarithromycin on the QT interval was studied in a group of 28 children treated for respiratory tract infections. QTc was measured before and following 24 h of treatment. A modest (average 22 ms, 95% CI 14-30 ms)...